Suspension of trading

Financial Ratios Sonnet Biotherapeutics

Stocks

SONN

US83548R4020

Market Closed - Nasdaq Other stock markets 08:00:00 03/12/25 am AEDT			5-day change	1st Jan Change
1.260 ^USD	-59.35%		-.--%	-

17/12	Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025	CI
03/12	Top Midday Decliners	MT

a01f24a1ed74fadc32a04.tAnjKpQ-a20Aj1RyQNfmIkY4VFrQWGfAwgUf72eM8-U.xmqMecRtMwI1vXkmKZLTaw0LY26XCSC4ijd1217ToYmEWJlF0HhdCC3IDQ

Published financial data: SONNET BIOTHERAPEUTICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	484K	350K	148K	18.63K	1M
Total Revenues	484K	350K	148K	18.63K	1M
Cost of Goods Sold, Total	16.63M	21.44M	11.81M	5.74M	8.36M
Gross Profit	-16.15M	-21.09M	-11.67M	-5.72M	-7.36M
Selling General & Admin Expenses, Total	8.94M	8.58M	7.13M	6.13M	8.49M
R&D Expenses	-	-	-	-	-
Other Operating Expenses, Total	8.94M	8.58M	7.13M	6.13M	8.49M
Operating Income	-25.09M	-29.67M	-18.79M	-11.85M	-15.84M
Interest Expense, Total	-	-	-	-	-556K
Interest And Investment Income	15	-	-	-	-
Net Interest Expenses	15	-	-	-	-556K
Currency Exchange Gains (Loss)	-22.04K	-52.48K	-40.08K	84.29K	-113K
Other Non Operating Income (Expenses)	-	-	-	4.33M	720K
EBT, Excl. Unusual Items	-25.11M	-29.72M	-18.83M	-7.44M	-15.79M
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	126K	-	-	-	-
EBT, Incl. Unusual Items	-24.98M	-29.72M	-18.83M	-7.44M	-15.79M
Income Tax Expense	-	-	-	-	218K
Earnings From Continuing Operations	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Net Income to Company	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Net Income - (IS)	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Net Income to Common Excl. Extra Items	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Per Share Items
Net EPS - Basic	-	-1.2K	-145.12	-11.35	-3.92
Basic EPS - Continuing Operations	-	-1.2K	-145.12	-11.35	-3.92
Basic Weighted Average Shares Outstanding	-	24.7K	130K	655K	4.08M
Net EPS - Diluted	-	-1.2K	-145.12	-11.35	-3.92
Diluted EPS - Continuing Operations	-	-1.2K	-145.12	-11.35	-3.92
Diluted Weighted Average Shares Outstanding	-	24.7K	130K	655K	4.08M
Normalized Basic EPS	-	-751.92	-90.7	-7.09	-2.42
Normalized Diluted EPS	-	-751.92	-90.7	-7.09	-2.42
Supplemental Items
EBITDA	-25.07M	-29.66M	-18.78M	-11.84M	-15.83M
EBITA	-25.09M	-29.67M	-18.79M	-11.85M	-15.84M
EBIT	-25.09M	-29.67M	-18.79M	-11.85M	-15.84M
EBITDAR	-24.96M	-29.56M	-18.68M	-11.74M	-15.74M
Effective Tax Rate - (Ratio)	-	-	-	-	-1.38
Normalized Net Income	-15.69M	-18.58M	-11.77M	-4.65M	-9.87M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	8.94M	8.58M	7.13M	6.13M	8.49M
Research And Development Expense From Footnotes	16.63M	21.44M	11.81M	5.74M	8.36M
Net Rental Expense, Total	115K	100K	96.82K	92.31K	94.12K
Imputed Operating Lease Interest Expense	-	-	-	-	4.72M
Imputed Operating Lease Depreciation	-	-	-	-	-4.63M
Stock-Based Comp., COGS (Total)	423K	438K	121K	109K	66.9K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	953K	438K	127K	122K	133K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.38M	876K	249K	231K	200K

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	27.62M	3.05M	2.27M	149K	5.12M
Total Cash And Short Term Investments	27.62M	3.05M	2.27M	149K	5.12M
Other Receivables	-	-	787K	762K	515K
Total Receivables	-	-	787K	762K	515K
Prepaid Expenses	1.19M	2.36M	1.68M	1.21M	471K
Restricted Cash	-	-	-	-	8.24M
Total Current Assets	28.81M	5.41M	4.74M	2.12M	14.34M
Net Property Plant And Equipment	182K	303K	227K	144K	54.68K
Deferred Charges Long-Term	-	113K	49.99K	15K	-
Other Long-Term Assets, Total	-	-	414K	494K	487K
Total Assets	28.99M	5.83M	5.43M	2.77M	14.88M
Liabilities
Accounts Payable, Total	3.78M	4.75M	2.2M	2.18M	2.94M
Accrued Expenses, Total	2.31M	3.19M	3.23M	941K	1.11M
Short-term Borrowings	748	748	-	-	-
Current Portion of Leases	94.52K	51.33K	73.05K	84.29K	46.57K
Unearned Revenue Current, Total	516K	166K	18.63K	-	-
Other Current Liabilities	-	-	2.55K	1.82K	1.55K
Total Current Liabilities	6.7M	8.16M	5.52M	3.21M	4.1M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	30.61K	204K	131K	46.57K	-
Total Liabilities	6.73M	8.37M	5.66M	3.26M	4.1M
Preferred Stock Convertible	-	-	-	-	1
Total Preferred Equity	-	-	-	-	1
Common Stock, Total	6.02K	554	175	65	708
Additional Paid In Capital	83.94M	88.87M	110M	117M	144M
Retained Earnings	-61.69M	-91.41M	-110M	-118M	-134M
Total Common Equity	22.26M	-2.54M	-226K	-486K	10.79M
Total Equity	22.26M	-2.54M	-226K	-486K	10.79M
Total Liabilities And Equity	28.99M	5.83M	5.43M	2.77M	14.88M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	24.45K	45.08K	384K	3.01M	7.08M
ECS Total Common Shares Outstanding	24.45K	31.5K	219K	650K	7.08M
Book Value / Share	910.35	-80.59	-1.03	-0.75	1.52
Tangible Book Value	22.26M	-2.54M	-226K	-486K	10.79M
Tangible Book Value Per Share	910.35	-80.59	-1.03	-0.75	1.52
Total Debt	126K	256K	204K	131K	46.57K
Net Debt	-27.5M	-2.8M	-2.07M	-18.59K	-5.07M
Debt Equivalent Oper. Leases	921K	801K	775K	738K	753K
Account Code - Inventory Valuation	-	3	3	3	3
Full Time Employees	9	12	12	13	9

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	-24.98M	-29.72M	-18.83M	-7.44M	-16.01M
Depreciation & Amortization - CF	95.16K	93.26K	75.75K	83.12K	89.26K
Depreciation & Amortization, Total	95.16K	93.26K	75.75K	83.12K	89.26K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	556K
Asset Writedown & Restructuring Costs	-	971K	282K	12K	114K
Stock-Based Compensation (CF)	1.38M	876K	249K	231K	200K
Other Operating Activities, Total	-125K	-	-	372K	523K
Change In Accounts Payable	1.72M	971K	-2.63M	48.42K	630K
Change in Unearned Revenues	16.37K	-350K	-148K	-18.63K	-
Change In Income Taxes	-	-	-69.27K	-	-
Change in Other Net Operating Assets	-654K	-528K	-267K	-1.9M	1.07M
Cash from Operations	-22.55M	-27.69M	-21.34M	-8.61M	-12.83M
Capital Expenditure	-3.62K	-	-	-	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-896K	-443K	-12K	-12K
Cash from Investing	-3.62K	-896K	-443K	-12K	-12K
Short Term Debt Issued, Total	-	-	-	-	2.02M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	2.02M
Short Term Debt Repaid, Total	-20.44K	-	-748	-	-
Total Debt Repaid	-20.44K	-	-748	-	-
Issuance of Common Stock	42.85M	1.84M	21.01M	6.88M	18.99M
Issuance of Preferred Stock	-	2.17M	-	-	5.5M
Other Financing Activities, Total	-	-	-	-385K	-465K
Cash from Financing	42.83M	4.01M	21.01M	6.49M	26.05M
Net Change in Cash	20.27M	-24.57M	-779K	-2.12M	13.21M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-13.13M	-18.14M	-14.63M	-8.93M	-15.75M
Unlevered Free Cash Flow	-13.13M	-18.14M	-14.63M	-8.93M	-15.96M
Change In Net Working Capital	-1.09M	-333K	2.76M	1.83M	6.33M
Net Debt Issued / Repaid	-20.44K	-	-748	-	2.02M

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	-84.78	-106.5	-208.63	-180.62	-112.17
Return on Total Capital	-121.74	-184.48	1.02K	3.93K	-188.99
Return On Equity %	-197.66	-301.42	1.36K	2.09K	-310.85
Return on Common Equity	-197.66	-301.42	1.36K	2.09K	-310.85
Margin Analysis
Gross Profit Margin %	-3.34K	-6.03K	-7.89K	-30.7K	-735.53
SG&A Margin	1.85K	2.45K	4.82K	32.92K	848.88
EBITDA Margin %	-5.18K	-8.47K	-12.71K	-63.55K	-1.58K
EBITA Margin %	-5.19K	-8.48K	-12.71K	-63.62K	-1.58K
EBIT Margin %	-5.19K	-8.48K	-12.71K	-63.62K	-1.58K
Income From Continuing Operations Margin %	-5.17K	-8.49K	-12.74K	-39.93K	-1.6K
Net Income Margin %	-5.17K	-8.49K	-12.74K	-39.93K	-1.6K
Net Avail. For Common Margin %	-5.17K	-8.49K	-12.74K	-39.93K	-1.6K
Normalized Net Income Margin	-3.24K	-5.31K	-7.96K	-24.96K	-987.07
Levered Free Cash Flow Margin	-2.71K	-5.18K	-9.9K	-47.96K	-1.57K
Unlevered Free Cash Flow Margin	-2.71K	-5.18K	-9.9K	-47.96K	-1.6K
Asset Turnover
Asset Turnover	0.03	0.02	0.03	0	0.11
Fixed Assets Turnover	2.12	1.44	0.56	0.1	10.07
Short Term Liquidity
Current Ratio	4.3	0.66	0.86	0.66	3.5
Quick Ratio	4.12	0.37	0.55	0.28	1.38
Operating Cash Flow to Current Liabilities	-3.36	-3.39	-3.86	-2.68	-3.13
Average Days Payable Outstanding	64.06	72.63	107.42	139.88	111.96
Long Term Solvency
Total Debt/Equity	0.57	-10.08	-90.23	-26.94	0.43
Total Debt / Total Capital	0.56	-11.21	-923.97	-36.88	0.43
LT Debt/Equity	0.14	-8.03	-57.91	-9.59	-
Long-Term Debt / Total Capital	0.14	-8.93	-592.97	-13.12	-
Total Liabilities / Total Assets	23.23	143.55	104.16	117.53	27.52
EBIT / Interest Expense	-	-	-	-	-28.49
EBITDA / Interest Expense	-	-	-	-	-28.31
(EBITDA - Capex) / Interest Expense	-	-	-	-	-28.31
Total Debt / EBITDA	-0.01	-0.01	-0.01	-0.01	-0
Net Debt / EBITDA	1.1	0.09	0.11	0	0.32
Total Debt / (EBITDA - Capex)	-0.01	-0.01	-0.01	-0.01	-0
Net Debt / (EBITDA - Capex)	1.1	0.09	0.11	0	0.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-27.64	-57.76	-87.4	5.27K
Gross Profit, 1 Yr. Growth %	63.51	30.61	-44.69	-50.98	28.62
EBITDA, 1 Yr. Growth %	44.08	18.27	-36.68	-36.97	33.78
EBITA, 1 Yr. Growth %	44.09	18.26	-36.66	-36.95	33.71
EBIT, 1 Yr. Growth %	44.09	18.26	-36.66	-36.95	33.71
Earnings From Cont. Operations, 1 Yr. Growth %	2.96	18.96	-36.64	-60.51	115.29
Net Income, 1 Yr. Growth %	2.96	18.96	-36.64	-60.51	115.29
Normalized Net Income, 1 Yr. Growth %	43.99	18.37	-36.64	-60.51	112.35
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-87.95	-92.18	-65.44
Net Property, Plant and Equip., 1 Yr. Growth %	-33.43	66.13	-25.02	-36.61	-62.01
Total Assets, 1 Yr. Growth %	262.68	-79.89	-6.87	-48.96	437.15
Tangible Book Value, 1 Yr. Growth %	637.1	-111.4	-91.1	114.95	-2.32K
Common Equity, 1 Yr. Growth %	637.1	-111.4	-91.1	114.95	-2.32K
Cash From Operations, 1 Yr. Growth %	44.43	22.77	-23.16	-59.67	49.02
Capital Expenditures, 1 Yr. Growth %	-95.24	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	48.16	38.16	-18.96	-38.93	76.26
Unlevered Free Cash Flow, 1 Yr. Growth %	48.16	38.16	-18.96	-38.93	78.59
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-44.72	-76.93	160.11
Gross Profit, 2 Yr. CAGR %	-	46.14	-15.01	-47.93	-20.6
EBITDA, 2 Yr. CAGR %	-	30.54	-13.46	-36.82	-8.18
EBITA, 2 Yr. CAGR %	130.83	30.54	-13.45	-36.8	-8.18
EBIT, 2 Yr. CAGR %	130.83	30.54	-13.45	-36.8	-8.18
Earnings From Cont. Operations, 2 Yr. CAGR %	126.47	10.67	-13.18	-49.98	-7.79
Net Income, 2 Yr. CAGR %	126.47	10.67	-13.18	-49.98	-7.79
Normalized Net Income, 2 Yr. CAGR %	127.04	30.55	-13.4	-49.98	-8.42
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	-90.29	-83.56
Net Property, Plant and Equip., 2 Yr. CAGR %	-	5.16	11.61	-31.05	-50.93
Total Assets, 2 Yr. CAGR %	2.6K	-14.6	-56.73	-31.06	65.57
Tangible Book Value, 2 Yr. CAGR %	179.69	-8.31	-89.92	-56.26	590.92
Common Equity, 2 Yr. CAGR %	179.69	-8.31	-89.92	-56.26	590.92
Cash From Operations, 2 Yr. CAGR %	218.32	33.16	-2.72	-44.33	-22.47
Levered Free Cash Flow, 2 Yr. CAGR %	484.69	43.08	5.56	-29.65	3.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	496.91	43.08	5.56	-29.65	4.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-66.23	41.91
Gross Profit, 3 Yr. CAGR %	-	-	5.71	-29.25	-29.62
EBITDA, 3 Yr. CAGR %	-	-	2.57	-22.14	-18.87
EBITA, 3 Yr. CAGR %	264.37	84.71	2.58	-22.12	-18.87
EBIT, 3 Yr. CAGR %	264.37	84.71	2.58	-22.12	-18.87
Earnings From Cont. Operations, 3 Yr. CAGR %	202.76	82.73	-8.1	-33.23	-18.63
Net Income, 3 Yr. CAGR %	202.76	82.73	-8.1	-33.23	-18.63
Normalized Net Income, 3 Yr. CAGR %	203.26	82.73	2.6	-33.34	-19
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-85.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-6.05	-7.57	-43.48
Total Assets, 3 Yr. CAGR %	1.65K	427.35	-12.1	-54.28	36.67
Tangible Book Value, 3 Yr. CAGR %	110.36	-3.73	-57.86	-72.06	61.97
Common Equity, 3 Yr. CAGR %	110.36	-3.73	-57.86	-72.06	61.97
Cash From Operations, 3 Yr. CAGR %	222.55	131.71	10.98	-27.46	-22.7
Levered Free Cash Flow, 3 Yr. CAGR %	-	261.48	18.19	-12.04	-4.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	266.49	18.19	-12.04	-4.03
Compound Annual Growth Rate Over Five Years
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-5.73
EBITDA, 5 Yr. CAGR %	-	-	-	-	-1.87
EBITA, 5 Yr. CAGR %	-	-	105.04	20.27	-1.87
EBIT, 5 Yr. CAGR %	-	-	105.04	20.27	-1.87
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	83.7	8.83	-7.98
Net Income, 5 Yr. CAGR %	-	-	83.7	8.83	-7.98
Normalized Net Income, 5 Yr. CAGR %	-	-	83.7	8.83	-1.96
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-27.54
Total Assets, 5 Yr. CAGR %	-	-	298.26	133.7	13.24
Tangible Book Value, 5 Yr. CAGR %	-	-	-37.61	-29.78	29
Common Equity, 5 Yr. CAGR %	-	-	-37.61	-29.78	29
Cash From Operations, 5 Yr. CAGR %	-	-	99.69	31.06	-3.86
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	87.65	12.19
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	89.21	12.48